Supply Chain | November 12, 2021
Jubilant Biosys expands Chemistry Innovation Research Centre
The centre has an initial capacity of 500 FTEs
The centre has an initial capacity of 500 FTEs
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Key takeaways of recent quarter & conference call highlights
The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
Subscribe To Our Newsletter & Stay Updated
